Advertisement

Topics

Nice piece by @damiangarde on the softness in DTC genomics. I wonder how much is plateauing for @23andme and @ancestry, and how much is other players realizing they, well, don't need as many micro-arrays. https://www.statnews.com/2019/07/12/illumina-earni

14:54 EDT 12 Jul 2019 | STAT

Nice piece by on the softness in DTC genomics. I wonder how much is plateauing for and , and how much is other players realizing they, well, don't need as many micro-arrays. https://www.statnews.com/2019/07/12/illumina-earnings-points-to-worrying-signs-for-consumer-genetics-industry/ …

Original Article: Nice piece by @damiangarde on the softness in DTC genomics. I wonder how much is plateauing for @23andme and @ancestry, and how much is other players realizing they, well, don't need as many micro-arrays. https://www.statnews.com/2019/07/12/illumina-earni

NEXT ARTICLE

More From BioPortfolio on "Nice piece by @damiangarde on the softness in DTC genomics. I wonder how much is plateauing for @23andme and @ancestry, and how much is other players realizing they, well, don't need as many micro-arrays. https://www.statnews.com/2019/07/12/illumina-earni"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...